Potential Uses of Intravenous Proton Pump Inhibitors to Control Gastric Acid Secretion

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Digestion

• Publication date

  2000-09-27

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000007798PMID 11025353
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Symptomatic Gastroesophageal Reflux in Acutely Hospitalized Patients

  2004cited by this paper
• Characterization of gastrointestinal bleeding in severely ill hospitalized patients

  2000cited by this paper
• Stress Ulcer Prophylaxis in Medical ICU Patients: Annual Utilization in Relation to the Incidence of Endoscopically Proven Stress Ulceration

  1998cited by this paper
• Intravenous (IV) pantoprazole (PANTO) rapidly and effectively controls acid output (AO) in patients with zollinger-ellison syndrome (ZES)

  1998cited by this paper
• The pharmacodynamics of lansoprazole administered via gastrostomy as intact, non‐encapsulated granules

  1998cited by this paper
• Comparison of intravenous with oral pantoprazole in symptom relief and healing of reflux esophagitis

  1998cited by this paper
• Proton Pump Inhibitors

  1998cited by this paper
• Pantoprazole in patients with varying degree of liver impairment in comparison to heal thy controls

  1998cited by this paper
• Considerations for long-term use of proton-pump inhibitors.

  1998cited by this paper
• Equipotent inhibition of gastric acid secretion by equal doses of oral or intravenous pantoprazole

  1998cited by this paper
• Proton-pump inhibitors in acid-related diseases.

  1998cited by this paper
• Clinical efficacy and safety of intravenous pantoprazole in gastroesophageal reflux disease (GERD)

  1998cited by this paper
• A prospective randomized comparative trial showing that omeprazole prevents rebleeding in patients with bleeding peptic ulcer after successful endoscopic therapy.

  1998cited by this paper
• A prospective study of omeprazole suspension to prevent clinically significant gastrointestinal bleeding from stress ulcers in mechanically ventilated trauma patients.

  1998cited by this paper
• Hyperoxia exacerbates microvascular lung injury following acid aspiration.

  1997cited by this paper
• Efficacy of primed infusions with high dose ranitidine and omeprazole to maintain high intragastric pH in patients with peptic ulcer bleeding: a prospective randomised controlled study.

  1997cited by this paper
• Current Guidelines on Stress Ulcer Prophylaxis

  1997cited by this paper
• A review of stress ulcer prophylaxis in the neurosurgical intensive care unit.

  1997cited by this paper
• Comparison of Omeprazole and Ranitidine for Stress Ulcer Prophylaxis

  1997cited by this paper
• Effect of omeprazole on the outcome of endoscopically treated bleeding peptic ulcers. Randomized double-blind placebo-controlled multicentre study.

  1997cited by this paper
• Nasogastric omeprazole: effects on gastric pH in critically Ill patients.

  1997cited by this paper
• An analysis of upper GI endoscopy done for patients in surgical intensive care: high incidence of, and morbidity from reflux oesophagitis.

  1997cited by this paper
• Continuous intravenous infusion of omeprazole in elderly patients with peptic ulcer bleeding. Results of a placebo-controlled multicenter study.

  1997cited by this paper
• Proton-pump inhibitors: three of a kind?

  1997cited by this paper
• Proton pump inhibitors in acute healing and maintenance of erosive or worse esophagitis: a systematic overview.

  1997cited by this paper
• Stress ulcer prophylaxis: the case for a selective approach.

  1997cited by this paper
• Stress ulcer prophylaxis in critically ill patients. Resolving discordant meta-analyses.

  1996cited by this paper
• Proton pump inhibitors: new drugs and indications.

  1996cited by this paper
• Optimizing the intragastric pH as a supportive therapy in upper GI bleeding.

  1996cited by this paper
• Pantoprazole, a new proton-pump inhibitor, has a precise and predictable profile of activity

  1996cited by this paper
• A prospective study of simplified omeprazole suspension for the prophylaxis of stress-related mucosal damage.

  1996cited by this paper
• A Comparison of Lansoprazole, Omeprazole, and Ranitidine for Reducing Preoperative Gastric Secretion in Adult Patients Undergoing Elective Surgery

  1996cited by this paper
• Gastroesophageal reflux disease. Current strategies for patient management.

  1996cited by this paper
• Nosocomial pneumonia in ventilated trauma patients during stress ulcer prophylaxis with sucralfate, antacid, and ranitidine.

  1996cited by this paper
• Zollinger-Ellison Syndrome

  1996cited by this paper
• Acid aspiration prophylaxis for emergency Caesarean section

  1996cited by this paper
• Acid aspiration induced lung injury. New insights and therapeutic options.

  1996cited by this paper
• A step-wise protocol for stress ulcer prophylaxis in the neurosurgical intensive care unit.

  1996cited by this paper
• The efficacy and optimum time of administration of ranitidine in the prevention of the acid aspiration syndrome

  1996cited by this paper
• Pantoprazole Review of its Pharmacological Properties and Therapeutic Use in Acid-Related Disorders

  1996cited by this paper
• GASTROESOPHAGEAL REFLUX DISEASE : CURRENT STRATEGIES FOR PATIENT MANAGEMENT

  1996cited by this paper
• The Effect of Three Different Ranitidine Dosage Regimens on Reducing Gastric Acidity and Volume in Ambulatory Surgical Patients

  1995cited by this paper
• Prospective double-blind placebo-controlled randomized trial on the use of ranitidine in preventing postoperative gastroduodenal complications in high-risk neurosurgical patients.

  1995cited by this paper
• Beneficial effects of I.V. omeprazole (OME) in patients with peptic ulcer bleeding (PUB)

  1995cited by this paper
• Effect of parenteral omeprazole and ranitidine on gastric pH and the outcome of bleeding peptic ulcer.

  1995cited by this paper
• Similarities and differences in the properties of substituted benzimidazoles: a comparison between pantoprazole and related compounds.

  1995cited by this paper
• A comparison of intravenous ranitidine and omeprazole on gastric volume and pH in women undergoing emergency Caesarean section

  1995cited by this paper
• The pharmacology of the gastric acid pump: the H+,K+ ATPase.

  1995cited by this paper
• Intravenous omeprazole and blindness

  1994cited by this paper
• Pharmacokinetics‐‐a relevant factor for the choice of a drug?

  1994cited by this paper
• Intravenous administration of the proton pump inhibitor omeprazole reduces the risk of acid aspiration at emergency cesarean section.

  1994cited by this paper
• Endoscopic ultrasonographic evaluation of gastric ulcer healing on treatment with proton pump inhibitors versus H2-receptor antagonists.

  1994cited by this paper
• Bleeding peptic ulcer.

  1994cited by this paper
• Diurnal secretory patterns and tolerance during individually titrated infusions of ranitidine.

  1993cited by this paper
• Bleeding duodenal ulcer. Role of gastric acid hypersecretion.

  1993cited by this paper
• Continuous intravenous famotidine for haemorrhage from peptic ulcer.

  1992cited by this paper
• Twenty-four-hour intragastric pH patterns in ICU patients on ranitidine

  1992cited by this paper
• The potential clinical role of intravenous omeprazole.

  1992cited by this paper
• Omeprazole versus placebo for acute upper gastrointestinal bleeding: randomised double blind controlled trial.

  1992cited by this paper
• RANDOMIZED DOUBLE-BLIND CONTROLLED TRIAL OF INTRAVENOUS FAMOTIDINE INFUSION IN 1005 PATIENTS WITH PEPTIC-ULCER BLEEDING

  1991cited by this paper
• Pharmacokinetics of oral and intravenous omeprazole in patients with the Zollinger-Ellison syndrome.

  1991cited by this paper
• Stress‐induced gastroduodenal lesions and total parenteral nutrition in critically ill patients: Frequency, complications, and the value of prophylactic treatment. A prospective, randomized study

  1991cited by this paper
• Intravenous omeprazole in patients with Zollinger-Ellison syndrome undergoing surgery.

  1990cited by this paper
• Intravenous therapy with high doses of ranitidine and omeprazole in critically ill patients with bleeding peptic ulcerations of the upper intestinal tract: an open randomized controlled trial.

  1990cited by this paper
• Effect of intravenous omeprazole on intragastric pH during intravenous infusion of amino acids

  1990cited by this paper
• Tolerance to oral H2-receptor antagonists

  1990cited by this paper
• Loss of acid suppression during dosing with H2‐receptor antagonists

  1990cited by this paper
• Consensus conference: Therapeutic endoscopy and bleeding ulcers.

  1989cited by this paper
• Factors influencing the development of gastrointestinal complications after neurosurgery: results of multivariate analysis.

  1989cited by this paper
• Stress ulcer prophylaxis in critically ill patients.

  1989cited by this paper
• Stress ulcer prophylaxis in medical patients: who, what, and how much?

  1988cited by this paper
• Effect of omeprazole on acute gastric stress ulceration in cervical cord transected rats

  1987cited by this paper
• Comparative efficacy of parenteral histamine (H2)-antagonists in acid suppression for the prevention of stress ulceration.

  1987cited by this paper
• Intravenous omeprazole: effect on 24-hour intragastric pH in duodenal ulcer patients.

  1986cited by this paper
• Gastrointestinal complications in critically ill patients: the intensivists' overview.

  1986cited by this paper
• Treatment with histamine H2 antagonists in acute upper gastrointestinal hemorrhage. Implications of randomized trials.

  1985influential reference
• Effects of a proton pump inhibitor, omeprazole, on gastric secretion and gastric and duodenal ulcers or erosions in rats

  1984cited by this paper
• Prevention of acute gastrointestinal complications after severe head injury: A controlled trial of cimetidine prophylaxis

  1981cited by this paper
• Prevention of acute gastrointestinal complications after severe head injury: a controlled trial of cimetidine prophylaxis.

  1980cited by this paper
• H2 receptor antagonists.

  1978cited by this paper

• Effectiveness of a Pharmacist-Led Intervention to Reduce Acid Suppression Therapy for Stress Ulcer Prophylaxis in ICUs in China: A Multicenter, Stepped-Wedge, Cluster-Randomized Controlled Trial

  2025influential citation
• A narrative review on fecal microbiota transplantation routes in ulcerative colitis: identifying the optimal approach across key parameters

  2025cites this paper
• Pharmacist‐Led Intervention on the Inappropriate Use of Stress Ulcer Prophylaxis Pharmacotherapy in Intensive Care Units: A Systematic review

  2021cites this paper
• Use of proton pump inhibitors in patients with COVID-19 infection: Are we doing more harm than good?

  2020cites this paper
• Drug Utilization Pattern of Proton Pump Inhibitors in the Department of General Medicine.

  2019cites this paper
• Interaction between Proton Pump Inhibitors and Antiplatelet Therapy

  2017cites this paper
• Prospective Assessment of Prescribing Pattern of Intravenous Proton Pump Inhibitors in an Indian Tertiary-Care Teaching Hospital

  2015cites this paper
• BUDGET IMPACT ANALYSIS OF USING OMEPRAZOLE IMMEDIATE-RELEASE ORAL SUSPENSION IN REPLACE OF INTRAVENOUS PANTOPRAZOLE IN CRITICALLY ILL PATIENTS.

  2015cites this paper
• The comparison of extemporaneous preparations of omeprazole, pantoprazole oral suspension and intravenous pantoprazole on the gastric pH of critically ill-patients

  2015cites this paper
• Uso inapropriado de inibidores da bomba de protões num serviço de medicina interna

  2014cites this paper
• Unexplained abdominal pain as a driver for inappropriate therapeutics: an audit on the use of intravenous proton pump inhibitors

  2014cites this paper
• Clinical Medicine insights: Gastroenterology pantoprazole for the Treatment of peptic Ulcer Bleeding and prevention of Rebleeding

  2012cites this paper
• Periampullary mass—a rare presentation of poorly differentiated neuroendocrine cancer of duodenum in a young adult: a case report and review of literature

  2012cites this paper
• Phase I, multicenter, randomized, open-label study evaluating the pharmacokinetics and safety profile of repeated once-daily doses of intravenous esomeprazole in children 0 to 17 years of age.

  2012cites this paper
• Stress-related mucosal disease: incidence of bleeding and the role of omeprazole in its prophylaxis.

  2010cites this paper
• Clinical and cost impact of intravenous proton pump inhibitor use in non-ICU patients.

  2010cites this paper
• Inappropriate utilization of intravenous proton pump inhibitors in hospital practice--a prospective study of the extent of the problem and predictive factors.

  2010cites this paper
• Esomeprazole: a proton pump inhibitor

  2009cites this paper
• [The influence of fibrinolytic and heparin therapy in acute myocardial infarction upon gastrointestinal bleeding in patients with asymptomatic ulcerous disease].

  2009cites this paper
• Greater Immediate Gastric Acid Suppression with Lansoprazole 30 mg Administered as a 2‐Minute Intravenous Bolus Injection versus a 30‐Minute Infusion

  2008cites this paper
• Tratamiento farmacológico de la hemorragia digestiva por úlcera péptica

  2006cites this paper
• Lansoprazole regimens that sustain intragastric pH >6.0: an evaluation of intermittent oral and continuous intravenous infusion dosages

  2006cites this paper
• Intravenous proton pump inhibitors.

  2006cites this paper
• [Pharmacological treatment of bleeding peptic ulcer].

  2006cites this paper
• Comparison of the effects of intravenously and orally administered esomeprazole on acid output in patients with symptoms of gastro‐oesophageal reflux disease

  2005cites this paper
• Science review: The use of proton pump inhibitors for gastric acid suppression in critical illness

  2004cites this paper
• Esomeprazole 40 mg i.v. provides faster and more effective intragastric acid control than pantoprazole 40 mg i.v.: results of a randomized study

  2004cites this paper
• High‐dose intravenous proton pump inhibition following endoscopic therapy in the acute management of patients with bleeding peptic ulcers in the USA and Canada: a cost‐effectiveness analysis

  2004cites this paper
• Omeprazole is More Effective than Famotidine for Preventing Acute Gastritis in Rats

  2004cites this paper
• The cost‐effectiveness of high‐dose oral proton pump inhibition after endoscopy in the acute treatment of peptic ulcer bleeding

  2004cites this paper
• A Comparison of Efficacy between Rebamipide and Omeprazole in the Treatment of NSAIDs Gastropathy

  2004cites this paper
• Pantoprazol por via subcutânea e cicatrização de sutura gástrica em ratos

  2003cites this paper
• Estudio de minimización de costes en la prescripción de inhibidores de la bomba de protones intravenosos: pantoprazol versus omeprazol

  2003influential citation
• Optimal Treatment of Zollinger-Ellison Syndrome and Related Conditions in Elderly Patients

  2003cites this paper
• Pharmacologic Properties of Proton Pump Inhibitors

  2003cites this paper
• Management of Duodenal Ulcer with Gastroesophageal Reflux Disease (GERD) with Intravenous Pantoprazole

  2003cites this paper
• Intravenous Administration of Pantoprazole

  2002cites this paper
• Pantoprazole IV

  2001cites this paper
• Proton Pump Inhibitor (PPI) Overuse in Hospitalized Patients

  year unknowncites this paper